Sodium lactate injection

Potassium phosphate injection Ringer s injection Lactated ringer s injection Sodium acetate injection Sodium bicarbonate injection Sodium chloride injection Sodium lactate injection Sodium phosphate injection... 

Calamine Ephedrine Lithium carbonate Milk of Magnesia Magnesium stearate Sodium lactate Injection. 

Sodium Lactate Injection 10.0 ml Methyl Orange Each ml 0.1 N H2S04 = 0.01121 g of CjHjNaOj... 

IV administration - Administer over approximately 30 minutes. Reconstitute with 50 or 100 ml of a compatible IV fluid. Cefepime is compatible at concentrations of 1 to 40 mg/mL with 0.9% Sodium Chloride Injection, 5% and 10% Dextrose Injection, M/6 Sodium Lactate Injection, 5% Dextrose and 0.9% Sodium Chloride Injection, Lactated Ringers and 5% Dextrose Injection, Normosol-R or Normosol-M in 5% Dextrose injection. 

D5W injection, D5W, 0.45% sodium chloride, and 0.15% potassium chloride injection, sodium lactate injection (M/6)... 

Commonly administered LVPs include such products as Lactated Ringers Injection USP, Sodium Chloride Injection USP (0.9%), which replenish fluids and electrolytes, and Dextrose Injection USP (5%), which provides fluid plus nutrition (calories), or various combinations of dextrose and saline. In addition, numerous other nutrient and ionic solutions are available for clinical use, the most popular of which are solutions of essential amino acids or lipid emulsions. These solutions are modified to be hypertonic, isotonic, or hypotonic to aid in maintaining both fluid, nutritional, and electrolyte balance in a particular patient according to need. Indwelling needles or catheters are required in LVP administration. Care must be taken to avoid local or systemic infections or thrombophlebitis owing to faulty injection or administration technique. 

Compatibility/Stability- Esmolol, at a final concentration of 10 mg/mL, is compatible with the following solutions and is stable for 24 hours or more at controlled room temperature or under refrigeration 5% dextrose injection 5% dextrose in Lactated Ringer s injection 5% dextrose in Ringer s injection 5% dextrose and 0.9% or 0.45% sodium chloride injection Lactated Ringer s injection potassium chloride (40 mEq/L) in 5% dextrose injection 0.9% or 0.45% sodium chloride injection. 

Sodium Chloride Injection, Dextrose 5% in 0.45% Sodium Chloride, Ringer s or Lactated Ringer s Injection). Infuse slowly IV over not less than 15 minutes, 30 minutes before beginning cancer chemotherapy repeat every 2 hours for 2 doses, then every 3 hours for 3 doses. 

IV infusion (20 or 40 mg) over 10 to 30 minutes A solution for IV infusion is prepared by first reconstituting the contents of 1 vial with 5 ml of 0.9% sodium chloride injection, lactated Ringer s injection, or 5% dextrose injection, and further diluting the resulting solution to a final volume of 50 ml. The solution (admixture) should be administered as an IV infusion over a period of 10 to 30 minutes. 

Compatible IV solutions - 0.9% sodium chloride injection, 5% dextrose (D5W) injection, D5W/0.9% sodium chloride injection, D5W in Ringer s lactate, Plasma-Lyte... 

Do not add additives or other medications to IV moxifloxacin or infuse simultaneously through the same IV line. If the same IV line is used for sequential infusion of other drugs, or if the piggyback method of administration is used, flush the line before and after infusion of moxifloxacin IV with a compatible solution. Moxifloxacin IV is compatible with the following IV solutions at ratios from 1 10 to 10 1 0.9% sodium chloride injection, IM sodium chloride injection, 5% dextrose injection, sterile water for injection, 10% dextrose for injection, Lactated Ringer s for injection. 

IV administration Administer over a period of 30 to 120 minutes. Do not use IV infusion bag in series connections. Do not introduce additives into this solution. Do not administer concomitantly with another drug administer each drug separately. Compatible IV solutions 5% dextrose injection, 0.9% sodium chloride injection lactated Ringer s injection. 

Pentozocine Lactate Injections of pentozocine lactate are incompatible with sodium bicarbonate, barbiturates, diazepam, chlordiazepoxide, glycopyrronium bromide, and nafcillin sodium. Dependence, withdrawal, and treatment of adverse effects are generally similar to those of opioid analgesics. 

For IV infusion, inamrinone lactate and milrinone lactate Injection solutions may be diluted In sodium chloride solution for injection. Inamrinone lactate for injection is preserved with sodium metabisulfite and needs protection from light. It should not be diluted with solutions containing dextrose, because a chemical Interaction occurs over 24 hours. For milrinone, an immediate chemical interaction with furosemide with the formation of a precipitate is observed when furosemide is injected into an infusion of milrinone. Patients who are sensitive to bisulfites also may be sensitive to inamrinone lactate injection, which contains sodium metabisulfite. 

Compound Injection of Sodium Lactate, P.P., Volhard 0 003546 g total Cl. 

Compound Injection of Sodium Lactate, B.P. A solution of lactic acid 0 25 per cent w v neutralised with sodium hydroxide, containing sodium chloride 0 6 per cent, potassium chloride 0 04 per cent, and calcium chloride 0-04 per cent. 

In addition to these forms of water, several other official aqueous vehicles can be used. These are isotonic injections that can be sterilised, eg, sodium chloride. Ringer s, dextrose, dextrose and sodium chloride, and lactated Ringer s. Addition of water-miscible solvents such as ethanol or propylene glycol increases solubiUty and stabiUty. 

Injection 50 mg calcium glycerophosphate and 50 mg calcium lactate per 10 ml in sodium chloride solution (0.08 mEq Ca/mL) (Rx) Calphosan (Glenwood)... 

Remifentanil Hydrochloride Remifentanil hydrochloride should not be mixed with lactated Ringer s injection, 5% glucose injection, or blood products. Solutions of remifentanil hydrochloride are incompatible with chlorpromazine hydrochloride, remifentanil, cefoperazone sodium, and amphotericin.84... 

Metabolic blood parameters are assayed in anesthetized male rats using a modified method of glucose clamp studies in rodents (Terrettaz and Jeanrenaud 1983). Four to 6 rats per group (vehicle control and one dose of the candidate compound) are used. Rats are anesthetized with an intraperitoneal injection of pentobarbital sodium (60 mg/kg), tracheotomized, and one jugular vein per rat is cannulated for intravenous infusion the other vein is prepared for collection of blood samples. Anesthesia is maintained for up to 7 hours by subcutaneous infusion of pentobarbital sodium (adjusted to the anesthetic depth of the individual animal about 24 mg/kg/h). Body temperature is monitored with a rectal probe thermometer, and temperature is maintained at 37 °C by means of a heated surgical table. Blood samples for glucose analysis (10 il) are obtained from the tip of the tail every 15 minutes, and for lactate analysis (20 p.1) every... 

Oral and parenteral do.sagc forms of ganciclovir are available. but oral bioavailability is poor. Only 5 to IO r of an oral dose is absorbed. Intravenous administration is preferable. More than 90% of the unchanged drug is excreted in the urine. Ganciclovir for injection is available as a lyophili/ed sodium salt for reconstitution in normal saline. S% dextrose in water, or lactated Ringer s solution. These. solutions are stningly alkaline (pH 11) and must be administered by slow, constant, intravenous infusion to avoid thrombophlebitis. 

Soffer, L. J., Dantes, D. A., and Sobotka, H., Utilization of intravenously injected sodium D-lactate as a test of hepatic function. Arch, haemal Med. 62, 918 (1938). 

Among single drug component studies, usual vehicles for dilution are 5% dextrose (D5W), 0.9% sodium chloride (normal saline, NS), aqueous buffers, peritoneal dialysis fluid, nonaqueous solvents, water for injection, phosphate-buffered saline, bacteriostatic water for injection, bacteriostatic sodium chloride. Ringer s injection, and lactated Ringer s. Stability studies can also be carried out on the drug product solution as such or in specific containers or injection devices. Solutions and suspensions can also be prepared extemporaneously and stability tested to show worthiness for oral, ophthalmic, or rectal administration. The following is an example of the first... 

---